Congenital hepatic hemangiomas are rare benign vascular tumors present at birth. They often are asymptomatic but can have significant complications and mortality that directly correlate with the tumor characteristics and size. Congenital hemangiomas generally regress during the first year of life and are managed medically or surgically depending on its course. We present a case of a full-term newborn with a symptomatic giant congenital hepatic hemangioma that received propranolol and corticosteroid therapy.
ChioreanLX-WCuiTannapfelA. Benign liver tumors in pediatric patients: review with emphasis on imaging features. World J Gastroenterol. 2015;21(28):8541.
NasseriEPiramMMcCuaigCCKoktaVDuboisJPowellJ.Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 2014;70(1):75-79.
9.
DickieBDasguptaRNairR. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009;44(1):125-133.
10.
DroletBAFrommeltPCChamlinSL. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128-140.
11.
SolmanLGloverMBeattieP. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. Br J Dermatol. 2018;179(3):582-589.
12.
KrowchukDPFriedenIJManciniAJ. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475.
MoJQDimashkiehHHBoveKE.GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol. 2004;35(2):200-209.
16.
KawaharaYNijimaHSuzukiYFurukawaRMorimotoA.Successful use of propranolol for congenital hepatic hemangioma with Kasabach–Merritt phenomenon. Pediatr Int. 2017;59(5):634-636.
17.
KassarjianAZurakowskiDDuboisJPaltielHJFishmanSJBurrowsPE.Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. Am J Roentgenol. 2004;182(3):785-795.
BaselgaECordiscoMGarzonMLeeMAlomarABleiF.Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series. Br J Dermatol. 2008;158(6):1363-1370.
20.
SarkarMMullikenJBKozakewichHRobertsonRLBurrowsPE.Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100(6):1377-1386.
21.
MahajanPMargolinJIacobasI.Kasabach-Merritt phenomenon: classic presentation and management options. Clin Med Insights Blood Disord. 2017;10:1179545X17699849.
22.
GorincourGKoktaVRypensFGarelLPowellJDuboisJ.Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol. 2005;35(12):1178-1185.
CabritaSVGonçalvesSRodriguesHGuerraNMouraP.Antenatal diagnosis of congenital hepatic hemangioma: a case report. Cases J. 2009;2(1):6829.
29.
ZenzenWPerez-AtaydeARElisofonSAKimHBAlomariAI.Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol. 2009;39(10):1118-1123.
30.
LekwuttikarnRJosephsSTengJ.Successful medical management of life-threatening hepatic hemangioma in neonates. Pediatrics. 2019.
31.
ZhuZCaiPZhuJ. Neonatal giant hepatic hemangioma: a case report. Medicine (Baltimore). 2018;97(42):e12863.
32.
ProkuratAKlugePChrupekMKościeszaARajszysP.Hemangioma of the liver in children: proliferating vascular tumor or congenital vascular malformation. Med Pediatr Oncol. 2002;39(5):524-529.
33.
DocxMKFVandenberghePDe BroekVGovaertP.Propranolol therapy for an abdominal giant haemangioma in a neonate. J Nepal Paediatr Soc. 2015;35(2):189-191.
34.
VanlanderADecaluweWVandelanotteMVan GeetCCornetteL.Propranolol as a novel treatment for congenital visceral haemangioma. Neonatology. 2010;98(3):229-231.
35.
AlamoLPerrinLVialYAnooshiravaniMMeuliR.Prenatal imaging of congenital hepatic tumors: a report of three cases. Clin Imaging. 2017; 41:112-117.
36.
AlyMMHamzaAFKaderHMASaafanHAGhazyMSRagabIA.Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. Eur J Pediatr. 2015;174(11):1503-1509.
37.
ÖzçayFUsluN.A new perspective for infantile hepatic hemangioma in the age of propranolol: experience at Baskent University. Exp Clin Transplant. 2017; 2:74-78.
